7-(2-amino-1-hydroxy-ethyl)-4-hydroxyb enzothiazol-2(3H)-one-derivatives as beta2 adrenoceptor agonists

Details for Australian Patent Application No. 2006285448 (hide)

Owner AstraZeneca AB

Inventors Connolly, Stephen; Pairaudeau, Garry; Stocks, Michael; Bailey, Andrew; Bonnert, Roger; Ingall, Anthony

Agent Freehills

Pub. Number AU-A-2006285448

PCT Pub. Number WO2007/027134

Priority 0501905-4 29.08.05 SE; 0601331-2 15.06.06 SE

Filing date 28 August 2006

Wipo publication date 8 March 2007

International Classifications

C07D 277/68 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

6 March 2008 PCT application entered the National Phase

  PCT publication WO2007/027134 Priority application(s): WO2007/027134

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006285453-Manufacture of chromatography matrices

2006285446-Treatment of inflammatory bowel disease